Methoxyflurane Instead of Morphine in Acute Coronary Syndrome Patients: Results of the Randomized Controlled METHANE-SIRIO 4 Study.
Thrombosis and Haemostasis · 2025-09-18 · Randomised trial
Abstract
AIM: Morphine is known to negatively influence the pharmacokinetics (PK) and the antiplatelet effect of oral P2Y12 receptor inhibitors administered due to an acute coronary syndrome. Worldwide studies of the potential approaches to overcome the undesired morphine effect have been only partially successful. The aim of the METHANE-SIRIO 4 study was to evaluate the PK and pharmacodynamics of ticagrelor and its active metabolite in unstable angina (UA) patients treated with morphine or methoxyflurane. METHODS AND RESULTS: Consecutive patients diagnosed with UA, randomized into the study arms, underwent the assessment of platelet reactivity using the Multiplate analyzer at nine predefined study time points. Serum concentrations of ticagrelor and its active metabolite, AR-C124910XX, were measured for each study participant. Median platelet reactivity was significantly lower in patients who received ticagrelor and methoxyflurane versus ticagrelor alone at 30 minutes postticagrelor loading dose. A trend toward lower reactivity was observed at 45 and 240 minutes. Significant differences in median serum concentrations of ticagrelor and its active metabolite were most pronounced between patients treated with ticagrelor and methoxyflurane versus ticagrelor and morphine. CONCLUSION: Co-administration of methoxyflurane in acute coronary syndrome patients allows for the avoidance of negative effects of morphine and has the additional effect of inhibiting platelet reactivity. Further randomized studies would be recommended to support these findings.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Analgesics · Antithrombotics & thrombolytics · Morphine · Methoxyflurane · P2Y12 inhibitors
Related articles
- Effects of morphine and P2Y inhibitor amongst patients with acute coronary syndrome: A meta-analysis of comparative studies. (Am J Emerg Med, 2023)
- Effects of morphine on P2Y12 platelet inhibitors in patients with acute myocardial infarction: A meta-analysis. (Am J Emerg Med, 2021)
- Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis. (Clin Pharmacol Ther, 2020)
- Morphine in acute coronary syndrome: systematic review and meta-analysis. (BMJ Open, 2019)
- Treatment of acute coronary syndrome by ground and helicopter ambulance services in Poland: a five-year retrospective study. (Front Public Health, 2026)
- Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndrome receiving Ticagrelor - The COMET (Comparison Morphine, Fentayl and Ticagrelor) randomized controlled trial. (Int J Cardiol, 2021)